Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide add-on in elderly with refractory partial seizures
NCT01546688Phase 4Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 4, randomised, double-blind trial in focal seizures comparing Zonisamide with Placebo (2 arms). Primary endpoints: Change From Baseline in CVST of the FePsy Test (Mean Reaction Time) at Week 16 and Change From Baseline in Bond and Lader Visual Analogue Scale (VAS) Mood Sub-Scores for Sedation at Week 16. Started Nov 2008; status: terminated.
02
Drugs
zonisamide
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT01546688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01546688.